Profilo
Ranjan Batra currently works at Dyne Therapeutics, Inc., as Chief Scientific Officer from 2025 and Lexeo Therapeutics, Inc., as Vice President-Research & Translation.
Dr. Batra also formerly worked at Locanabio, Inc., as SVP-Research & Development.
Dr. Batra received his doctorate degree from the University of Florida.
Posizioni attive di Ranjan Batra
| Società | Posizione | Inizio |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 28/04/2025 |
Precedenti posizioni note di Ranjan Batra
| Società | Posizione | Fine |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Corporate Officer/Principal | 02/04/2025 |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Ranjan Batra
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to treat muscle diseases | Health Technology |
Locanabio, Inc.
Locanabio, Inc. Packaged SoftwareTechnology Services Develops and operates software platform for addressing a wide spectrum of human genetic diseases | Technology Services |
Lexeo Therapeutics Inc
Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
















